Ophthalmic light sensitive nanocarrier systems
- 1 February 2008
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 13 (3-4), 124-134
- https://doi.org/10.1016/j.drudis.2007.12.005
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- AQ4, an antitumor anthracenedione, inhibits endothelial cell proliferation and vascular endothelial growth factor secretion: Implications for the therapy of ocular neovascular disordersEuropean Journal of Pharmacology, 2007
- ART AND SCIENCE OF PHOTODYNAMIC THERAPYClinical and Experimental Pharmacology and Physiology, 2006
- Luminescent Quantum Dots: A Very Attractive and Promising Tool in BiomedicineCurrent Medicinal Chemistry, 2006
- Light-induced gene transfer from packaged DNA enveloped in a dendrimeric photosensitizerNature Materials, 2005
- Gene Therapy for Genetic and Acquired Retinal DiseasesSurvey of Ophthalmology, 2002
- Photochemical Transfection: A Technology for Efficient Light-Directed Gene DeliverySomatic Cell and Molecular Genetics, 2002
- The role of cytokines in corneal immunopathology.Ocular Immunology and Inflammation, 2001
- [Potential of photodynamic therapy with a second-generation sensitizer: mono-L-aspartyl chlorin e6].1997
- Triggered release of hydrophilic agents from plasmologen liposomes using visible light or acidBiochimica et Biophysica Acta (BBA) - Biomembranes, 1992
- TYPE I and TYPE II PHOTOSENSITIZATION BY THE ANTIBACTERIAL DRUG NALIDIXIC ACID. A LASER FLASH PHOTOLYSIS STUDY*Photochemistry and Photobiology, 1991